KM

Kanchan Manakchand Rajawat

Active Director Director DIN 08244119
DIN 08244119 First appointment Sep 2018 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2018
Shareholding value •••• Premium profile

About Kanchan Manakchand Rajawat

Data last updated:

Kanchan Manakchand Rajawat is a Director at Suchand Pharma Private Limited (since 2018). The company operates in Trading. Suchand Pharma Private Limited reported revenue of ₹2.62 Cr (FY 2024).

DIN 08244119
Primary Designation Director
Industry Trading
First Appointment 29 Sep 2018
Oldest Company Age 8 yrs
Largest company Suchand Pharma Private Limited · ₹2.62 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Suchand Pharma Private Limited U51909MH2018PTC315046
Director29 Sep 20182018₹2.62 Cr (FY 2024)Active

Board colleagues of Kanchan Manakchand Rajawat

Directorship timeline

Open interactive timeline →
Suchand Pharma Private Limited
Premium access

Shareholding and investment profile for Kanchan Manakchand Rajawat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kanchan Manakchand Rajawat

Kanchan Manakchand Rajawat currently holds 1 directorship: Suchand Pharma Private Limited (Director, since 29 Sep 2018, revenue ₹2.62 Cr (FY 2024)).

Kanchan Manakchand Rajawat was first appointed on 29 Sep 2018 as Director at Suchand Pharma Private Limited.

The current boards of Kanchan Manakchand Rajawat's companies include Gaurav Manakchand Rajawat (Suchand Pharma Private Limited), Ronak Manakchand Rajawat (Suchand Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available